Clues of HLAs, metabolic SNPs, and epigenetic factors in T cell-mediated drug hypersensitivity reactions. [PDF]
Molatefi R +10 more
europepmc +1 more source
Omeprazole Induced Rapid Drug Reaction with Eosinophilia, Systemic Symptoms, and Cross-Reactivity in Delayed-Type Hypersensitivity Associated with Proton-Pump Inhibitors: A Case Report and Literature Review [PDF]
Kanokkarn Pinyopornpanish +6 more
openalex +1 more source
This scoping review examined models estimating long‐term radiation risks from repeated mammography screening. While modelling indicates the risks are low, approaches vary by protocol and vendor. Emerging AI tools show promise for improving personalised risk estimation, though further development is needed for cross‐platform compatibility.
Nazli A. Moda +3 more
wiley +1 more source
Evaluation of the frequency and characteristics of drug hypersensitivity reactions in hospitalized children: Real life-cohort study. [PDF]
Büyük Yaytokgil Ş +8 more
europepmc +1 more source
Detection in vitro of cellular hypersensitivity to drugs
Ross E. Rocklin, John R. David
openalex +1 more source
Multiple drug hypersensitivity to beta lactam and non beta lactam antibiotics, inhibitors of conversion enzyme, thiopental and COX2 inhibitors on a hyperthyroid male patient ‐ case report [PDF]
Celina Silvia Stafie
openalex +1 more source
Abstract Background Alveolar bone loss challenges tooth retention and implant placement. Freeze‐dried bone allograft (FDBA) is widely used for alveolar ridge preservation but has limitations in resorption rate and healing time. In this proof‐of‐concept study, we tested whether pro‐mineralization enzyme, tissue‐nonspecific alkaline phosphatase (TNAP ...
Kedith Sawangsri +4 more
wiley +1 more source
Global differences and risk factors influencing drug hypersensitivity quality of life: A multicenter, multiethnic study of drug allergy across 3 continents. [PDF]
Copaescu AM +5 more
europepmc +1 more source
Abstract Ustekinumab (UST) is a monoclonal antibody used in the management of moderate to severe inflammatory bowel disease. While generally well‐tolerated, serious adverse reactions, including hypersensitivity and anaphylaxis, have been documented, specifical following the initial intravenous (IV) dose.
Kennedy Sparling +2 more
wiley +1 more source

